Tumor cells are positive for IHC markers, such as HepPar1, arginase1, glypican 3, pCEA, and CD10, and negative for AE1/AE3, CK7, CK13, CK19, CK20, CDX2, and CEA. Here, KRT19 is linked to neoplasm.